Back to Journals » Core Evidence

Core Evidence

ISSN: 1555-175X

Editor-in-Chief: Professor Garry Walsh

1555-1741 (Print) - went to online only in 2008

Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch. The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups. The journal encourages the submission of unsolicited review articles.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Note to authors: Before submitting your paper to Core Evidence please ensure you include the Levels of Evidence.

Indexed online:

  • Emerging Sources Citation Index (ESCI), from 2016
  • PubMed and PubMed Central (Core Evid)
  • Embase, from 2006 (Correct as at December 8, 2016)
  • Scopus, from 2006 to 2018
  • OAIster - The Open Access Initiative